FLACC1
geneOn this page
Summary
FLACC1 (flagellum associated containing coiled-coil domains 1, HGNC:14439) is a protein-coding gene on chromosome 2q33.1, encoding Flagellum-associated coiled-coil domain-containing protein 1 (Q96Q35).
Predicted to be located in cytoplasmic vesicle and outer dense fiber. Predicted to be active in cytoplasm.
Source: NCBI Gene 130540 — RefSeq curated summary.
At a glance
- GWAS associations: 17
- Clinical variants (ClinVar): 80 total
- MANE Select transcript:
NM_001127391
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:14439 |
| Approved symbol | FLACC1 |
| Name | flagellum associated containing coiled-coil domains 1 |
| Location | 2q33.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000155749 |
| Ensembl biotype | protein_coding |
| OMIM | 619796 |
| Entrez | 130540 |
Gene structure
Transcript identifiers
Ensembl transcripts: 10 — 7 protein_coding, 2 retained_intron, 1 protein_coding_CDS_not_defined
ENST00000286190, ENST00000392257, ENST00000405148, ENST00000415745, ENST00000418364, ENST00000425488, ENST00000439709, ENST00000448967, ENST00000494171, ENST00000494223
RefSeq mRNA: 3 — MANE Select: NM_001127391
NM_001127391, NM_001289993, NM_139163
CCDS: CCDS2346, CCDS46488
Canonical transcript exons
ENST00000392257 — 15 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001076302 | 201288271 | 201288781 |
| ENSE00001511250 | 201289696 | 201289785 |
| ENSE00003476532 | 201289457 | 201289566 |
| ENSE00003497193 | 201348254 | 201348302 |
| ENSE00003508276 | 201342370 | 201342431 |
| ENSE00003535634 | 201346542 | 201346675 |
| ENSE00003545149 | 201309151 | 201309250 |
| ENSE00003546406 | 201351292 | 201351451 |
| ENSE00003569041 | 201344170 | 201344263 |
| ENSE00003570069 | 201330736 | 201330833 |
| ENSE00003623865 | 201350711 | 201350782 |
| ENSE00003624320 | 201307519 | 201307622 |
| ENSE00003670033 | 201299238 | 201299300 |
| ENSE00003679717 | 201330470 | 201330522 |
| ENSE00003904935 | 201356982 | 201357345 |
Expression profiles
Bgee: expression breadth ubiquitous, 168 present calls, max score 96.25.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.1696 / max 32.2510, expressed in 51 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 33219 | 0.1426 | 49 |
| 33220 | 0.0271 | 8 |
Top tissues by expression
248 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| right uterine tube | UBERON:0001302 | 96.25 | gold quality |
| bronchial epithelial cell | CL:0002328 | 88.57 | gold quality |
| bronchus | UBERON:0002185 | 86.42 | gold quality |
| mucosa of paranasal sinus | UBERON:0005030 | 84.84 | gold quality |
| left testis | UBERON:0004533 | 83.91 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 83.90 | gold quality |
| right testis | UBERON:0004534 | 83.02 | gold quality |
| testis | UBERON:0000473 | 81.41 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 79.92 | gold quality |
| descending thoracic aorta | UBERON:0002345 | 77.71 | gold quality |
| cardiac muscle of right atrium | UBERON:0003379 | 77.17 | gold quality |
| heart left ventricle | UBERON:0002084 | 77.08 | gold quality |
| left ventricle myocardium | UBERON:0006566 | 77.05 | gold quality |
| ascending aorta | UBERON:0001496 | 76.65 | gold quality |
| thoracic aorta | UBERON:0001515 | 76.52 | gold quality |
| cardiac ventricle | UBERON:0002082 | 76.38 | gold quality |
| calcaneal tendon | UBERON:0003701 | 76.00 | gold quality |
| apex of heart | UBERON:0002098 | 75.72 | gold quality |
| right atrium auricular region | UBERON:0006631 | 75.48 | gold quality |
| cardiac atrium | UBERON:0002081 | 74.97 | gold quality |
| right lung | UBERON:0002167 | 74.75 | gold quality |
| bone marrow cell | CL:0002092 | 74.71 | gold quality |
| sural nerve | UBERON:0015488 | 74.70 | gold quality |
| heart | UBERON:0000948 | 74.53 | gold quality |
| aorta | UBERON:0000947 | 74.21 | gold quality |
| fallopian tube | UBERON:0003889 | 73.35 | gold quality |
| left coronary artery | UBERON:0001626 | 72.95 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 72.86 | gold quality |
| lower esophagus | UBERON:0013473 | 72.79 | gold quality |
| popliteal artery | UBERON:0002250 | 72.73 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 6.87 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
18 targeting FLACC1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-150-5P | 99.99 | 66.69 | 1976 |
| HSA-MIR-1250-3P | 99.96 | 70.04 | 4038 |
| HSA-MIR-30A-3P | 99.87 | 69.74 | 2928 |
| HSA-MIR-30D-3P | 99.87 | 69.92 | 2917 |
| HSA-MIR-30E-3P | 99.87 | 69.68 | 2942 |
| HSA-MIR-586 | 99.65 | 70.40 | 2051 |
| HSA-MIR-4276 | 99.56 | 67.66 | 2514 |
| HSA-MIR-186-3P | 99.51 | 66.24 | 1685 |
| HSA-MIR-513C-5P | 99.50 | 68.42 | 1730 |
| HSA-MIR-514B-5P | 99.50 | 68.19 | 1766 |
| HSA-MIR-4650-3P | 99.01 | 68.39 | 1062 |
| HSA-MIR-939-3P | 98.97 | 65.07 | 2347 |
| HSA-MIR-6501-3P | 98.71 | 67.45 | 1480 |
| HSA-MIR-676-5P | 98.49 | 68.87 | 1492 |
| HSA-MIR-6831-5P | 98.26 | 67.20 | 990 |
| HSA-MIR-3927-3P | 97.68 | 66.76 | 892 |
| HSA-MIR-5189-3P | 97.52 | 66.33 | 487 |
| HSA-MIR-6736-3P | 96.98 | 65.22 | 1342 |
Literature-anchored findings (GeneRIF, showing 2)
- Genome-wide association studies show a significant association between the intronic SNP rs1830298 in ALS2CR12 gene and breast cancer; further expression studies suggest that CASP8 might be the target gene. (PMID:25168388)
- rs13014235 is associated with susceptibility to cutaneous basal cell carcinoma. (PMID:25855136)
Cross-species orthologs
9 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Flacc1 | ENSMUSG00000047528 |
| rattus_norvegicus | Flacc1 | ENSRNOG00000024917 |
| caenorhabditis_elegans | WBGENE00007131 | |
| caenorhabditis_elegans | WBGENE00007132 | |
| caenorhabditis_elegans | WBGENE00007134 | |
| caenorhabditis_elegans | pals-3 | WBGENE00007657 |
| caenorhabditis_elegans | pals-5 | WBGENE00007659 |
| caenorhabditis_elegans | pals-6 | WBGENE00007660 |
| caenorhabditis_elegans | pals-13 | WBGENE00012505 |
Protein
Protein identifiers
Flagellum-associated coiled-coil domain-containing protein 1 — Q96Q35 (reviewed: Q96Q35)
Alternative names: Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 12 protein
All UniProt accessions (4): Q96Q35, C9JTY0, C9JZS0, H7C1T5
UniProt curated annotations — full annotation on UniProt →
Subcellular location. Cytoplasm. Cytoplasmic granule. Cell projection. Cilium. Flagellum.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q96Q35-1 | 1 | yes |
| Q96Q35-2 | 2 |
RefSeq proteins (3): NP_001120863, NP_001276922, NP_631902 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR026674 | FLACC1 | Family |
UniProt features (9 total): coiled-coil region 3, chain 1, region of interest 1, compositionally biased region 1, modified residue 1, splice variant 1, sequence variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q96Q35-F1 | 75.95 | 0.47 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (1): 376
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 55 (showing top):
GOCC_MOTILE_CILIUM, GOCC_CILIUM, BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_D, GOCC_OUTER_DENSE_FIBER, GOCC_9PLUS2_MOTILE_CILIUM, GOCC_SUPRAMOLECULAR_COMPLEX, GOCC_POLYMERIC_CYTOSKELETAL_FIBER, GOCC_SUPRAMOLECULAR_POLYMER, SRSF9_TARGET_GENES, MIR1250_3P, MIR4276, GSE14308_TH2_VS_TH1_DN, BLANCO_MELO_MERS_COV_INFECTION_MCR5_CELLS_UP, GSE15767_MED_VS_SCS_MAC_LN_UP, DESCARTES_FETAL_INTESTINE_ERYTHROBLASTS
GO Biological Process (0):
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (7): outer dense fiber (GO:0001520), cytoplasm (GO:0005737), cytoplasmic vesicle (GO:0031410), sperm flagellum (GO:0036126), cilium (GO:0005929), motile cilium (GO:0031514), cell projection (GO:0042995)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 2 |
| binding | 1 |
| sperm flagellum | 1 |
| polymeric cytoskeletal fiber | 1 |
| intracellular anatomical structure | 1 |
| cytoplasm | 1 |
| intracellular vesicle | 1 |
| 9+2 motile cilium | 1 |
| intraciliary transport particle | 1 |
| membrane-bounded organelle | 1 |
| plasma membrane bounded cell projection | 1 |
| cilium | 1 |
Protein interactions and networks
STRING
336 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| FLACC1 | CATSPERT | Q53TS8 | 511 |
| FLACC1 | ZNF404 | Q494X3 | 480 |
| FLACC1 | ATP6AP1L | Q52LC2 | 476 |
| FLACC1 | TRAK2 | O60296 | 448 |
| FLACC1 | LRRC37A2 | A6NM11 | 445 |
| FLACC1 | LRRC37A | A6NMS7 | 444 |
| FLACC1 | LRRC37A3 | O60309 | 434 |
| FLACC1 | ZNF155 | Q12901 | 431 |
| FLACC1 | CASP8 | Q14790 | 419 |
| FLACC1 | PLEKHD1 | A6NEE1 | 404 |
| FLACC1 | RCCD1 | A6NED2 | 396 |
| FLACC1 | BABAM1 | Q9NWV8 | 391 |
| FLACC1 | ANKRD34A | Q69YU3 | 372 |
| FLACC1 | ABHD8 | Q96I13 | 371 |
| FLACC1 | PPIL3 | Q9H2H8 | 371 |
IntAct
24 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| SULT2B1 | FLACC1 | psi-mi:“MI:0915”(physical association) | 0.760 |
| FLACC1 | SULT2B1 | psi-mi:“MI:0915”(physical association) | 0.760 |
| FLACC1 | STK16 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TCL1A | FLACC1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TXNDC5 | FLACC1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| FLACC1 | TCL1A | psi-mi:“MI:0915”(physical association) | 0.560 |
| FLACC1 | TXNDC5 | psi-mi:“MI:0915”(physical association) | 0.560 |
| FLACC1 | SRC | psi-mi:“MI:0915”(physical association) | 0.400 |
| FLACC1 | PIK3R1 | psi-mi:“MI:0915”(physical association) | 0.400 |
| FLACC1 | SPTAN1 | psi-mi:“MI:0915”(physical association) | 0.400 |
| FLACC1 | CLTA | psi-mi:“MI:0915”(physical association) | 0.400 |
| FLACC1 | MTUS2 | psi-mi:“MI:0915”(physical association) | 0.370 |
| FLACC1 | SNX3 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (42): ALS2CR12 (Two-hybrid), ALS2CR12 (Two-hybrid), ALS2CR12 (Two-hybrid), ALS2CR12 (Two-hybrid), ALS2CR12 (Two-hybrid), SULT2B1 (Two-hybrid), ALS2CR12 (Two-hybrid), ALS2CR12 (Two-hybrid), ALS2CR12 (Two-hybrid), ALS2CR12 (Two-hybrid), ALS2CR12 (Two-hybrid), ALS2CR12 (Two-hybrid), ALS2CR12 (Two-hybrid), ALS2CR12 (Two-hybrid), ALS2CR12 (Two-hybrid)
ESM2 similar proteins: A1L3H4, A5A777, A6H754, A7YY97, A9ULR1, B2GV52, C7GUN6, D3ZNV2, P05531, P0CAP1, P33716, P57679, P70281, Q03954, Q0IHJ3, Q28HY7, Q32L59, Q3UIJ9, Q4R764, Q4V9P3, Q58CS6, Q5EB94, Q5I0J4, Q5RA87, Q5XIC3, Q5ZK77, Q60547, Q60595, Q61806, Q63520, Q640Z7, Q6AY08, Q6CQ94, Q6NPG7, Q6P205, Q7L3B6, Q80Y56, Q810N9, Q8BXX9, Q8GYM3
Diamond homologs: Q6AY08, Q8BVM7, Q96Q35
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
80 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 63 |
| Likely benign | 9 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
2198 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 2:201288782:C:CC | acceptor_gain | 1.0000 |
| 2:201289428:A:AC | donor_gain | 1.0000 |
| 2:201289429:G:C | donor_gain | 1.0000 |
| 2:201289455:A:AC | donor_gain | 1.0000 |
| 2:201289456:C:CC | donor_gain | 1.0000 |
| 2:201289458:T:TA | donor_gain | 1.0000 |
| 2:201289475:T:TA | donor_gain | 1.0000 |
| 2:201289691:CTCA:C | donor_loss | 1.0000 |
| 2:201289692:TCAC:T | donor_loss | 1.0000 |
| 2:201289693:CA:C | donor_loss | 1.0000 |
| 2:201289695:CCT:C | donor_gain | 1.0000 |
| 2:201307514:GTTA:G | donor_loss | 1.0000 |
| 2:201307515:TTAC:T | donor_loss | 1.0000 |
| 2:201307516:TAC:T | donor_loss | 1.0000 |
| 2:201307517:AC:A | donor_loss | 1.0000 |
| 2:201307518:C:A | donor_loss | 1.0000 |
| 2:201307520:T:TA | donor_gain | 1.0000 |
| 2:201307623:C:CC | acceptor_gain | 1.0000 |
| 2:201309143:GTACT:G | donor_loss | 1.0000 |
| 2:201309147:TCACT:T | donor_loss | 1.0000 |
| 2:201309148:CACTT:C | donor_loss | 1.0000 |
| 2:201309149:A:AC | donor_gain | 1.0000 |
| 2:201309149:ACTTT:A | donor_loss | 1.0000 |
| 2:201309150:C:CA | donor_gain | 1.0000 |
| 2:201309150:CT:C | donor_gain | 1.0000 |
| 2:201309150:CTTT:C | donor_gain | 1.0000 |
| 2:201309150:CTTTG:C | donor_gain | 1.0000 |
| 2:201309246:CTGTC:C | acceptor_gain | 1.0000 |
| 2:201330739:G:C | donor_gain | 1.0000 |
| 2:201344163:CACT:C | donor_loss | 1.0000 |
AlphaMissense
0 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1000037238 (2:201324842 G>A), RS1000096649 (2:201302455 A>G), RS1000104899 (2:201332172 T>C), RS1000200445 (2:201312296 T>A), RS1000211649 (2:201359608 T>C), RS1000228137 (2:201304914 T>C), RS1000280238 (2:201305092 A>T), RS1000295416 (2:201352621 T>G), RS1000376154 (2:201339277 T>C), RS1000391532 (2:201291134 C>T), RS1000470905 (2:201330182 G>A), RS1000523009 (2:201330459 G>A,C,T), RS1000551051 (2:201348500 C>T), RS1000558840 (2:201302582 T>C), RS1000694243 (2:201291886 C>G,T)
Disease associations
OMIM: gene MIM:619796 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
17 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST002568_7 | Esophageal squamous cell carcinoma | 4.000000e-13 |
| GCST002842_11 | Basal cell carcinoma | 2.000000e-09 |
| GCST003726_11 | Basal cell carcinoma | 7.000000e-19 |
| GCST004607_249 | Plateletcrit | 1.000000e-09 |
| GCST004632_137 | Lymphocyte percentage of white cells | 1.000000e-12 |
| GCST004633_110 | Neutrophil percentage of white cells | 7.000000e-12 |
| GCST004988_16 | Breast cancer | 2.000000e-16 |
| GCST005896_50 | Non-melanoma skin cancer | 2.000000e-13 |
| GCST008870_5 | Keratinocyte cancer (MTAG) | 2.000000e-48 |
| GCST008871_65 | Basal cell carcinoma | 5.000000e-55 |
| GCST008872_6 | Squamous cell carcinoma | 2.000000e-07 |
| GCST010148_4 | Cutaneous squamous cell carcinoma | 3.000000e-09 |
| GCST010244_357 | Triglyceride levels | 4.000000e-08 |
| GCST011011_53 | Youthful appearance (self-reported) | 2.000000e-09 |
| GCST90002388_307 | Lymphocyte count | 1.000000e-40 |
| GCST90002389_135 | Lymphocyte percentage of white cells | 1.000000e-19 |
| GCST90002402_285 | Platelet count | 1.000000e-18 |
EFO canonical traits (9, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0007985 | platelet crit |
| EFO:0007993 | lymphocyte percentage of leukocytes |
| EFO:0007990 | neutrophil percentage of leukocytes |
| EFO:0009260 | non-melanoma skin carcinoma |
| EFO:0010176 | keratinocyte carcinoma |
| EFO:1001927 | cutaneous squamous cell carcinoma |
| EFO:0004530 | triglyceride measurement |
| EFO:0004587 | lymphocyte count |
| EFO:0004309 | platelet count |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
16 total (human), top 16 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Smoke | decreases expression, increases abundance, increases expression | 2 |
| aristolochic acid I | increases expression | 1 |
| sotorasib | decreases expression, affects cotreatment | 1 |
| triphenyl phosphate | affects expression | 1 |
| trichostatin A | affects expression | 1 |
| perfluorooctane sulfonic acid | decreases expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| trametinib | affects cotreatment, decreases expression | 1 |
| (+)-JQ1 compound | increases expression | 1 |
| NVP-BKM120 | affects cotreatment, decreases expression | 1 |
| Air Pollutants | increases abundance, increases expression | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Cadmium | decreases expression | 1 |
| Cisplatin | increases expression | 1 |
| Doxorubicin | decreases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
Cellosaurus cell lines
1 cell lines: 1 cancer cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_E1QC | HAP1 ALS2CR12 (-) | Cancer cell line | Male |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): basal cell carcinoma, esophageal squamous cell carcinoma, squamous cell carcinoma